Header cover image

Global Pharmaceuticals & Biotech Potential Opportunities

UPDATED Jun 27, 2022

Companies that are potentially undervalued based on future cash flows and market ratios.

370 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CELUCelularityUS$3.61-7.4%-64.5%US$513.9mUS$11.80PS20.9xE24.0%n/a
TILInstil BioUS$4.833.2%-74.8%US$624.0mUS$24.75PB1.2xE31.9%n/a
PLXPPLx PharmaUS$2.3410.9%-82.8%US$64.4mUS$14.00PS6.3xE51.1%n/a
AUTLAutolus TherapeuticsUS$2.7825.2%-59.7%US$252.8mUS$11.39PS113.5xE32.7%n/a
NVAXNovavaxUS$53.8233.7%-72.3%US$4.2bUS$151.86PS3xE-23.9%n/a
7079WDB cocoJP¥4,550.000.2%19.4%JP¥11.0bJP¥8,500.00PS16.8xn/an/a
6817Winston Medical SupplyLtdNT$67.40-3.6%-32.1%NT$1.2bn/aPS13.5xn/a5.9%
6539DV BiomedNT$59.10-0.8%-13.1%NT$3.5bn/aPS11.5xn/a9.8%
A003090Daewoong₩25,550.003.4%-45.2%₩1.1tn/aPS10.7xn/a0.4%
A002720Kukje Pharma₩4,960.002.2%-33.4%₩99.4bn/aPB1.4xn/a0%
A009300Sam-A Pharm₩15,050.000.7%-9.1%₩92.5bn/aPS13.1xn/a1.7%
2005SSY GroupHK$4.2712.4%-31.9%HK$11.7bHK$4.76PS16.2xE27.4%3.3%
2275Guilin Sanjin PharmaceuticalCN¥13.071.2%-0.6%CN¥7.5bn/aPS20.5xn/a7.7%
4Shenzhen GuoHua Network Security TechnologyCN¥9.18-1.6%-51.2%CN¥1.4bn/aPS5.4xn/an/a
2603Shijiazhuang Yiling PharmaceuticalCN¥24.243.4%16.4%CN¥41.3bCN¥31.49PS35.1xE24.9%1.2%
2422Sichuan Kelun PharmaceuticalCN¥19.18-0.2%-5.0%CN¥26.7bCN¥20.28PS22.1xE18.9%2.2%
600594Guizhou Yibai PharmaceuticalCN¥5.652.0%0.9%CN¥4.4bn/aPS20xn/a4.6%
600993Mayinglong Pharmaceutical GroupCN¥22.950.6%-15.7%CN¥9.8bn/aPS20.4xn/a1.5%
506879Gujarat Themis Biosyn₹421.206.4%33.8%₹6.1bn/aPS14xn/a1.4%
526953Venus Remedies₹209.6012.1%-46.0%₹2.8bn/aPS6.9xn/a0%
524506Coral Laboratories₹234.900.9%-47.4%₹843.1mn/aPS9.3xn/a0%
543298Vineet Laboratories₹60.501.0%-10.2%₹551.8mn/aPS8.4xn/a1.7%
511523Veerhealth Care₹12.005.3%13.4%₹84.9mn/aPS-86.3xn/an/a
530317Godavari Drugs₹61.305.2%-2.1%₹463.5mn/aPS8.8xn/an/a
Page 12 of 16